Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Nordic Phase II Study of Peripheral T-cell Lymphomas Based on Dose-intensive Induction and High-dose Consolidation With Autologous Stem Cell Rescue

NCT00791947 is registered in ClinicalTrials.gov with University of Aarhus as lead sponsor.

NCT NCT00791947
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00791947 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Nordic Phase II Study of Peripheral T-cell Lymphomas Based on Dose-intensive Induction and High-dose Consolidation With Autologous Stem Cell Rescue
Lead sponsor
University of Aarhus
Phase
Phase 2
Overall status
Completed
Start date
October 31, 2001
Completion date
August 31, 2010
Enrollment
166 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

peripheral t-cell lymphoma